Purpose: Tumors previously diagnosed as solitary fibrous tumors (SFT) and hemangiopericytomas (HPC) are characterized by the NAB2-STAT6 fusion gene, leading to nuclear STAT6 expression, and are now considered part of one SFT/HPC tumor entity by the 2016 World Health Organization Classification of Tumors of the Central Nervous System. We present the first primary choroidal SFT/HPC with the diagnosis confirmed by STAT6 expression. Procedures: A 51-year-old man underwent enucleation for a choroidal mass, which revealed a spindle cell neoplasm involving the optic nerve, without extrascleral extension. Immunohistochemical stains for S-100, melan-A, tyrosinase, and HMB45 were all negative; however, detection of monosomy 3 by FISH favored a choroidal spindle cell melanoma. Four years later, he presented with hepatic metastases of a spindle cell tumor, and a year later with an epithelioid malignancy involving the calvarium. Results: The calvarial tumor showed nuclear STAT6 immunoreactivity, supporting the diagnosis of SFT/HPC. Retrospectively, the choroidal and hepatic masses were also found to demonstrate nuclear STAT6 expression, supporting the diagnosis of a primary choroidal SFT/HPC with metachronous metastases to the liver and calvarium. Conclusions: This case highlights the significance of considering SFT/HPC in the diagnosis of intraocular spindle cell tumors and the importance of STAT6 immunohistochemistry in the evaluation of such tumors.

1.
Ji Y, Fan J, Xu Y, Zhou J, Zeng HY, Tan YS: Solitary fibrous tumor of the liver. Hepatobiliary Pancreat Dis Int 2006;5:151-153.
2.
Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M: Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013;45:131-132.
3.
Fritchie KJ, Jin L, Rubin BP, Burger PC, Jenkins SM, Barthelmess S, Moskalev EA, Haller F, Oliveira AM, Giannini C: NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor. J Neuropathol Exp Neurol 2016;75:263-271.
4.
Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM: Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013;45:180-185.
5.
Maat W, Jordanova ES, van Zelderen-Bhola SL, Barthen ER, Wessels HW, Schalij-Delfos NE, Jager MJ: The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 2007;131:91-96.
6.
Berghoff AS, Kresl P, Bienkowski M, Koelsche C, Rajky U, Hainfellner JA, Preusser M: Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma. Clin Neuropathol 2017;36:56-59.
7.
Cheah AL, Billings SD, Goldblum JR, Carver P, Tanas MZ, Rubin BP: STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics. Pathology 2014;46:389-395.
8.
Macagno N, Figarella-Branger D, Mokthari K, Metellus P, Jouvet A, Vasiljevic A, Loundou A, Bouvier C: Differential diagnosis of meningeal SFT-HPC and meningioma: which immunohistochemical markers should be used? Am J Surg Pathol 2016;40:270-278.
9.
Klemperer P, Rabin CB: Primary neoplasm of the pleura: a report of five cases. Arch Pathol Lab Med 1931;11:385-412.
10.
Kim KA, Gonzalez I, McComb JG, Giannotta SL: Unusual presentations of cerebral solitary fibrous tumors: report of four cases. Neurosurgery 2004;54:1004-1009; discussion 1009.
11.
Kuchelmeister K, Scheuerle A, Bohle RM, Kretschmer T, Richter HP, Schachenmayr W: Solitary fibrous tumor a new differential diagnosis in surgical neuropathology. Report of two cases (Abstract). Clin Neuropathol 1997;16:270.
12.
Martin AJ, Fisher C, Igbaseimokumo U, Jarosz JM, Dean AF: Solitary fibrous tumours of the meninges: case series and literature review. J Neurooncol 2001;54:57-69.
13.
Peng L, Liu Y, Ai Y, Liu Z, He Y, Liu Q: Skull base metastases from a malignant solitary fibrous tumor of the liver. A case report and literature review. Diagn Pathol 2011;6:127.
14.
Brown HH, Brodsky MC, Hembree K, Mrak RE: Supraciliary hemangiopericytoma. Ophthalmology 1991;98:378-382.
15.
Gieser SC, Hufnagel TJ, Jaros PA, MacRae D, Khodadoust AA: Hemangiopericytoma of the ciliary body. Arch Ophthalmol 1988;106:1269-1272.
16.
Papale JJ, Frederick AR, Albert DM: Intraocular hemangiopericytoma. Arch Ophthalmol 1983;101:1409-1411.
17.
Shimura M, Suzuki K, Fuse N, Yoshida M, Saiki Y, Ohtani H, Tamai M: Intraocular hemangiopericytoma. A case report. Ophthalmologica 2001;215:378-382.
18.
Ben-Izhak O, Stark P, Levy R, Bergman R, Lichtig C: Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am J Dermatopathol 1994;16:241-246.
19.
Heegaard S, Jensen OA, Prause JU: Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45. Melanoma Res 2000;10:350-354.
20.
Martins MC, Scull JJ, Alcocer CE, Deschenes J, Antecka E, Burnier MN Jr: Immunohistochemical expression of S-100 beta in choroidal melanomas. Can J Ophthalmol 1997;32:378-381.
21.
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-1225.
22.
Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE, Pusch S, Habel A, Meyer J, Gock T, Jones DT, Mawrin C, Schittenhelm J, Becker A, Heim S, Simon M, Herold-Mende C, Mechtersheimer G, Paulus W, Konig R, Wiestler OD, Pfister SM, von Deimling A: Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 2013;125:651-658.
23.
Laver NV, McLaughlin ME, Duker JS: Ocular melanoma. Arch Pathol Lab Med 2010;134:1778-1784.
24.
Shields JA, Shields CL: Posterior uveal melanoma: clinical and pathologic features; in Shields JA, Shields CL (eds): Intraocular Tumors: A Text and Atlas. Philadelphia, WB Sauders, 1992.
25.
Gao C, Zhang Y, Jing M, Qu W, Li J, Zhao XR, Yu YH: Postoperative radiotherapy for the treatment of solitary fibrous tumor with malignant transformation of the pelvic: a rare case report with literature review. Medicine (Baltimore) 2016;95:e2433.
26.
Xue Y, Chai G, Xiao F, Wang N, Mu Y, Wang Y, Shi M: Post-operative radiotherapy for the treatment of malignant solitary fibrous tumor of the nasal and paranasal area. Jpn J Clin Oncol 2014;44:926-931.
27.
Yang XJ, Zheng JW, Ye WM, Wang YA, Zhu HG, Wang LZ, Zhang ZY: Malignant solitary fibrous tumors of the head and neck: a clinicopathological study of nine consecutive patients. Oral Oncol 2009;45:678-682.
28.
Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM: Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 2011;117:4939-4947.
29.
Stacchiotti S, Libertini M, Negri T, Palassini E, Gronchi A, Fatigoni S, Poletti P, Vincenzi B, Dei Tos AP, Mariani L, Pilotti S, Casali PG: Response to chemotherapy of solitary fibrous tumour: a retrospective study. Eur J Cancer 2013;49:2376-2383.
30.
Stacchiotti S, Tortoreto M, Bozzi F, Tamborini E, Morosi C, Messina A, Libertini M, Palassini E, Cominetti D, Negri T, Gronchi A, Pilotti S, Zaffaroni N, Casali PG: Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clin Cancer Res 2013;19:5192-5201.
31.
DeVito N, Henderson E, Han G, Reed D, Bui MM, Lavey R, Robinson L, Zager JS, Gonzalez RJ, Sondak VK, Letson GD, Conley A: Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience. PLoS One 2015;10:e0140362.
32.
Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, Mathisen DJ, Lanuti M: Risk factor analysis for the recurrence of resected solitary fibrous tumours of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg 2013;44:111-117.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.